Listed below are the presentations and full reference information for a variety of BioMedEcon’s client research projects. All presentations have been posted with BioMedEcon client permission.

Allergy
Hankin CS (Invited Lecture). The health economics of allergen immunotherapy. Lecture scheduled to be presented at the 2012 Allergy Update (sponsored by the Allergy Asthma & Immunology Society of Ontario). Toronto, Canada; March 31, 2012.

Hankin CS (Invited Presentation). Cost effectiveness and compliance of specific immunotherapy. In: New Horizons – Specific Immunotherapy (SIT): Practical considerations. Oral presentation scheduled at the 2011 World Allergy Congress. Cancun, Mexico; December 4-8, 2011. More Info >

Hankin CS (Invited Presentation). Inner-city asthma: Barriers to access to care and implications for underserved populations. In: Environmental aspects of asthma.  Symposium to be presented at the 2011 World Allergy Congress. Cancun, Mexico. December 4-8, 2011. More Info >

Hankin CS (Invited Presentation). Is subcutaneous immunotherapy cost effective?  In: Novel Directions in Allergen Immunotherapy. Lecture to be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma, and Immunotherapy. Boston, MA. November 3-8, 2011. More Info >

Hankin CS (Invited Speaker). The present: health economic and immunotherapy. In: 100 Years of Allergy Immunotherapy: Past, Present and Future, presented at the 2011 Symposium presentation at the 2011 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. San Francisco, CA; March 18-22, 2011. Download PDF

Hankin CS (Invited Speaker). Allergen immunotherapy significantly reduces healthcare costs among U.S. adults with allergic rhinitis: A retrospective matched cohort study jointly funded by the AAAAI and ACAAI. Invited Forum Presentation to the Immunotherapy, Rhinitis, Sinusitis, Ocular Diseases and Cough (IRSOC) Interest Section at the 2011 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. San Francisco, CA; March 18-22, 2011. Download PDF

Hankin CS, Cox L, Wang Z, Bronstone A. Does allergen-specific immunotherapy provide cost benefits for children and adults with allergic rhinitis? Results from large-scale retrospective analyses jointly funded by AAAAI and ACAAI. Oral presentation at the 2011 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. San Francisco, CA; March 18-22, 2011. Download PDF

Wang Z, Hankin CS, Cox L, Bronstone A. Allergen immunotherapy significantly reduces healthcare costs among U.S. adults with allergic rhinitis: a retrospective matched cohort study jointly funded by the AAAAI and ACAAI. Poster presentation at the 2011 Annual Meeting of the American Academy of Allergy, Asthma, and Immunology. San Francisco, CA; March 18-22, 2011. Download PDF

Brown D, Hankin C, Scott D, Henry M, Anderson K, Wang Z. Characteristics associated with premature discontinuation of allergen immunotherapy among children and adults: findings from a large, single-specialty allergy practice in the United States.  Poster presented at the 2009 American Academy of Allergy, Asthma, and Immunology Annual Meeting. Washington, D.C.; March 13-19, 2009. Download PDF

Hankin C, Cox L, Lang D, Gross G, Fass P, Leatherman B, Bronstone A, Wang S. Does Allergy Immunotherapy Confer Healthcare Cost Benefits for Children with Allergic Rhinitis?  A Large-Scale, Retrospective, Claims-Based Study. Podium presentation at the American College of Allergy, Asthma, and Immunology 2008 Annual Meeting; Seattle, WA; November 6-11, 2008. Download PDF

Hankin C, Cox L, Lang D, Levin A, Gross G, Eavy G, Meltzer E, Burgoyne D, Bronstone A, Wang Z. Allergy immunotherapy among Medicaid-enrolled children with rhinitis: patterns of care, resource use, and costs. Podium presentation to the 134th American Public Health Association Annual Meeting. Washington, D.C.; November 3-7, 2007. Download PDF

Hankin CS, Cox L, Wang Z, Bronstone A. Allergy immunotherapy practice patterns and associated outcomes of care. J Allergy Clin Immunol 2007;1119(1): S159. Download PDF

Hankin C, Cox L, Lang D, Levin A, Gross G, Eavy G, Meltzer E, Burgoyne D, Bronstone A, Wang Z. Allergy immunotherapy among Medicaid-enrolled children with rhinitis: patterns of care, resource use, and costs. Podium presentation to the 12th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Arlington, VA; May 22, 2007. Download PDF

Hankin C, Cox L, Lang D, Levin A, Gross G, Eavy G, Meltzer E, Burgoyne D, Bronstone A, Wang Z. Allergy immunotherapy among Medicaid-enrolled children with rhinitis: patterns of care, resource use, and costs. Podium presentation to the Florida Allergy, Asthma, and Immunology Society’s 2007 Annual Meeting, Sarasota, FL; June 10, 2007. Download PDF

Hankin CS, Bordeaux M, Bronstone A. Sublingual immunotherapy (SLIT) in the U.S. Podium Presentation at the 63rd American Academy of Allergy, Asthma, and Immunology Annual Meeting, RSOD Interest Section Forum. San Diego, CA; February 25, 2007. Download PDF


Analgesia
Panchal SJ, Hankin CS, Schein J, Zhang M, Clark J. Under-delivery of analgesic associated with intravenous patient-controlled analgesia (IV PCA) infusion pumps: findings from the FDA manufacturer and user facility device experience (MAUDE) database. Poster presented at the American Society of Anesthesiologists Annual Meeting. Atlanta, GA; October 22-26, 2005. Download PDF

Hankin CS and Zhang M. Analysis of reported adverse events associated with intravenous patient-controlled analgesia: Findings from the FDA center for devices and radiological health manufacturer and user facility device experience (MAUDE) database. Poster presented at the 2005 Summer Meeting of the American Society of Health-System Pharmacists. Boston, MA; June 11-15, 2005. Download PDF

Hankin CS and Zhang M. Problems associated with intravenous patient-controlled analgesia (IV PCA) infusion pumps: an analysis of the manufacturer and user facility device experience (MAUDE) database. Poster presented at the 10th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Washington, D.C.; May 15-18, 2005. Download PDF


Dermatology
Kelechi T, Mueller M, Hankin C, Bronstone A, Samies J, Bonham P.  Safety and Efficacy Trial of a new membrane (pG1cNAc) in patients with venous leg ulcers. Poster presented at the 43rd Annual Conference of the Wound, Ostomy and Continence Nurses Society. New Orleans, LA; June 4-8, 2011. Download PDF

Hankin CS, Kelechi TJ, Mueller M, Bronstone A. Efficacy and safety of Poly-N-Acetyl-Glucosamine, nanofiber-derived advanced wound healing technology (pG1cNAc) for treatment of patients with venous leg ulcers:  a randomized, controlled, investigator-blinded pilot study. Poster presented at the 10th Annual Clinical Meeting of the American Professional Wound Care Association. Philadelphia, PA; March 31- April 3, 2011. Download PDF

Hankin CS, Lebwohl M, Knispel J, Dunn JD, Lopes M, Bronstone A, Wang Z. Patterns of care in the pharmacologic treatment of moderate-to-severe psoriasis. Poster presented at the American Academy of Dermatology 2009 Summer Academy Meeting. Boston, MA; July 29-August 2, 2009. Download PDF

Hankin CS, Gleeson J, Burgoyne D, Dunn J, Knispel J, Lopes M, Bronstone A. Comparative and Cost Effectiveness of Treatments for Moderate-to-Severe Psoriasis. Poster presented at the Academy of Managed Care Pharmacy 21st Annual Meeting and Showcase. Orlando, FL; April 15-28, 2009. Download PDF

Hankin CS, Feldman SR, Sczcotka A, Fish L, Hankin DL. Numbers-Needed-to-Treat (NNT) and Cost-Effectiveness (CE) of treatment for moderate-to-severe psoriasis. Poster presented at the 2005 Summer Meeting of the American Society of Health-System Pharmacists. Boston, MA; June 11-15, 2005. Download PDF

Hankin CS, Feldman SR, Sczcotka A, Fish L, Hankin DL. Numbers-Needed-to-Treat and associated costs of care for treatment for moderate-to-severe psoriasis. Poster presented at the 10th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Washington, D.C.; May 15-18, 2005. Download PDF

Hankin CS, Sczcotka A, Stinger R, Feldman, SR, Fish L, Scaraga E. Systematic review and cost-effectiveness analysis of treatments for moderate-to-severe psoriasis. Poster presented at the 17th Annual Meeting & Showcase of the Academy of Managed Care Pharmacy, Denver, CO, April 19-23, 2005. J Manag Care Pharmacy 2005;11(3): 282-3.
Download PDF and Download PDF

Hankin CS, Feldman, SR, Pearce D. Cost-effectiveness of treatment for moderate-to-severe psoriasis. Podium presentation at the International Society for Pharmacoeconomics and Health Outcomes Research 7th Annual European Congress. Hamburg, Germany; October 24-26, 2004.
Download PDF


Diabetes
Hanas R, Argadh C-D, Graham C, Gerhardsson P, Hankin CS. Clinical and economic outcomes of continuous glucose monitoring among Swedish residents with poorly controlled type 1 diabetes. Poster presented at the 4th Annual Conference of Advanced Technologies and Treatments for Diabetes. London, UK; February 16-19, 2011. Download PDF

Graham C, Agardh C, Gerhardsson P, Hankin CS. Comparison of total annual direct costs among Swedish residents with poorly controlled type 1 diabetes: standard care versus real-time continuous glucose monitoring.  Oral presentation at the 46th Annual Meeting of the European Association for the Study of Diabetes. Stockholm, Sweden; September 20-24, 2010. Download PDF

Graham C, Gerhardsson P, Hankin C. Impact of continuous glucose monitoring on reducing diabetes-related complications among Swedish persons with poorly-controlled type 1 diabetes: decision-tree analysis. Poster presented at the 3rd International Conference on Advanced Technologies & Treatments for Diabetes. Basel, Switzerland; February 10-13, 2010. Download PDF

Hankin C, Wang Z, Bronstone A, Brener B, Wu J. Role of gender on response to anti-diabetic medication. Poster presented at the 2006 Midyear Meeting of the American Society of Health-System Pharmacists. Anaheim, CA; December 2-7, 2006. Download PDF

Hankin C, Brener B, Wu J, Wang Z, Bronstone A. Disparity in response to metformin among obese versus non-obese type II diabetes patients. Poster presented at the 1st World Congress on Controversies in Obesity, Diabetes, and Hypertension. Berlin, Germany; October 26-29, 2006. Download PDF

Hankin C, Brener B, Wu J, Wang Z, Bronstone A. Comparison of treatment persistence with two different formulations of metformin. Poster presented at the 28th Annual Meeting of the Society for Medical Decision Making. Cambridge, MA; October 14-18, 2006. Download PDF


Dyslipidemia
Hankin C, Fish L, Dunn JD, Fenrick R, Bronstone A, Wang Z. Likelihood of initiating antilipidemics by patient sex, race/ethnicity, age, and comorbidity:  large-scale analysis of Florida Medicaid-enrolled adults with newly diagnosed dyslipidemia. Poster presented at the 10th European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Dublin, Ireland; October 20-23, 2007. Download Powerpoint File

Hankin C, Dunn JD, Fenrick R, Fish L, Wang Z, Bronstone A. Persistence to antilipidemics varies by sex, age, and race/ethnicity: analysis of a large-scale, retrospective claims database. Poster presented at the 10th European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Dublin, Ireland; October 20-23, 2007.
Download Powerpoint File


Endocrinology
Hankin, CS, Silverman L, Wang Z, Bronstone A. Association between central precocious puberty and psychiatric disorders: retrospective claims analysis of Florida Medicaid-enrolled children. Poster presented at the 161st Annual Meeting of the American Psychiatric Association; May 3-8, 2008; Washington, D.C. Download PDF

Hankin CS, Wang Z, Bronstone A. Adherence to monthly injectable leuprolide acetate among Florida Medicaid-enrolled children with central precocious puberty. Poster presented at the 42nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists; Las Vegas, NV; December 2-6, 2007. Download PDF

Hankin C, Silverman L, Wang Z, Bronstone A. Association between central precocious puberty and comorbid medical illness: large-scale retrospective claims analysis of Florida Medicaid-enrolled children. Poster presented at the 10th European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Dublin, Ireland; October 20-23, 2007. Download PDF


Obesity
Troupin B, Hankin CS. Low-dose controlled-release phentermine/topiramate (PHEN/TPM CR) results in significant weight loss and improves atherosclerotic biomarkers in overweight/obese patients with obesity-related comorbidities. Poster presented at the 2011 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Dallas, TX; March 2-5, 2011. Download PDF

Troupin B, Hankin CS.  Magnitude of weight loss conferred by controlled-release low-dose phentermine/topiramate (PHEN/TPM CR) determines extent of cardiometabolic benefit. Poster presented at the 2011 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Dallas, TX; March 2-5, 2011. Download PDF

Troupin B, Hankin CS.  Controlled-release low-dose phentermine/topiramate (PHEN/TPM CR) reduces weight, improves glycemic markers, and decreases progression to type 2 diabetes mellitus (T2DM) in overweight and obese patients with obesity-related comorbidities. Poster presented at the 2011 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Dallas, TX; March 2-5, 2011. Download PDF

Hankin CS (Session Chair, Moderator, and Presenter), DeGette D, Thorpe K, Pawlecki B, Lopes M.  U.S. obesity epidemic: A social justice issue. Invited Scientific Session at the 138th Annual Meeting of the American Public Health Association. Denver, CO; November 6-10, 2010.
Download PDF

Hankin CS, Bronstone, A, Troupin B. Ten percent or greater weight loss is a clinically meaningful outcome in the treatment of obesity. Poster presented at the 32nd Annual Meeting of the Society for Medical Decision Making. Toronto, Ontario; October 24-27, 2010. Download Poster

Hankin CS, Brunetti L, Knispel J, Troupin B. Comparative effectiveness of weight loss treatments: diet, pharmacologic agents, and bariatric surgery. Poster presented at the Academy of Managed Care Pharmacy 2010 Educational Conference. St. Louis, MO; October 13-15, 2010.
Download PDF

Hankin CS, Lopes M, Dunn JD, Troupin B. Meeting the increasing interest in coverage and reimbursement of obesity treatment: comparative effectiveness research methods. Poster presented at the Academy of Managed Care Pharmacy 2010 Educational Conference. St. Louis, MO; October 13-15, 2010. Download PDF

Troupin B, Hankin CS. Weight loss achieved with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR) is associated with improved blood pressure, lipid, and glycemic markers among overweight or obese patients with obesity-related comorbidities. Poster presented at the American Society for Health-System Pharmacists 2010 Summer Meeting. Tampa, FL; June 6-9, 2010. Download PDF

Psychiatric Disorders
Hankin CS, Bronstone, A, Zun L. Estimated United States incidence of physical assaults perpetrated by agitated adult patients with schizophrenia or bipolar disorder on nurses and physicians in the general emergency department. Poster presented at the American Society for Health-System Pharmacists 2010 Summer Meeting. Tampa, FL; June 6-9, 2010.
Download PDF

Hankin CS, Norris MM, Bronstone A. Estimated United States incidence and cost of emergency department staff assaults perpetrated by agitated adult patients with schizophrenia or bipolar disorder. Poster accepted for presentation at the 15th International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Atlanta, GA; May 15-19, 2010. Download Poster

Hankin CS, Dunn J, Knispel J, Levin A, Wang Z, Bronstone A. Comparison of healthcare burden of adult patients with “pure obsessive-compulsive disorder” versus “pure depression”: nine-year claims analysis of Florida Medicaid enrollees. Poster presented at the Academy of Managed Care Pharmacy 2008 Educational Conference. Kansas City, MO; October 15-17, 2008. Download Abstract PDF or Download Poster PDF

Hankin C, Koran LM, Culpepper L, Dunn JD, Black DW, Hollander E, Knispel J, Wang Z, Bronstone A, Dougherty DD, Levin A. Patients with “pure OCD” incur higher 2-year psychotropic costs than patients with “pure depression” (Abstract # P.4.a.013). Abstracts of the 21st European College of Neuropsychopharmacology Congress, 30 August-3 September 2008, Barcelona, Spain. Eur Neuropsychopharmacol 2008;18 Suppl 4:S153-615. Download Abstract PDF or Download Poster PDF

Hankin C, Wang Z, Bronstone A. Racial disparities in the initiation of psychotropics among Medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder: large-scale, retrospective Florida Medicaid claims analysis. Journal of Managed Care Pharmacy 2008; 14(2): 243. Download Abstract PDF DownloadPostert PDF

Hankin CS, Dunn JD, Knispel J, Levin A, Bronstone A, Wang Z. Adequacy of SSRI Pharmacotherapy among Medicaid-enrolled Patients Newly-diagnosed with Obsessive-Compulsive Disorder (Abstract # NR3-130). Poster presented at the 2008 Annual Meeting of the American Psychiatric Association. Washington, D.C.; May 3-8, 2008.Download Abstract PDF or Download Poster PDF

Hankin C, Knispel J, Dunn JD, Levin A, Cullpepper L, Dougherty D, Koran L, Hollander E, Sheehan D, Black D, Bronstone A, Wang Z. Health care use and costs of patients with "pure obsessive-compulsive disorder" versus "pure depression": 9-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid adults enrollees (Poster #PMH25). Value in Health 2008;11(3): A116. Download Abstract PDF or Download Poster PDF

Hankin C, Koran LM, Culpepper L, Knispel J, Dougherty D, Hollander E, Sheehan DV, Dunn JD, Black DW, Bronstone A, Wang Z. Comparison of healthcare use and costs of adult patients with “pure obsessive-compulsive disorder” versus “pure depression”:  nine-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid enrollees. Podium presentation at the 31st Annual Meeting of the Society for General Internal Medicine. Pittsburgh, PA; April 11, 2008. Download PDF

Hankin C, Koran LM, Culpepper L, Knispel J, Dougherty D, Hollander E, Sheehan DV, Dunn JD, Black DW, Bronstone A, Wang Z. Comparison of healthcare use and costs of adult patients with “pure obsessive-compulsive disorder” versus “pure depression”:  nine-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid enrollees. Journal of General Internal Medicine 2008; 23 (suppl 2): 269-270. Download PDF

Hankin C, Koran LM, Culpepper L, Knispel J, Dougherty D, Hollander E, Sheehan DV, Dunn JD, Black DW, Bronstone A, Wang Z. Comparison of healthcare use and costs of adult patients with “pure obsessive-compulsive disorder” versus “pure depression”:  nine-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid enrollees. Poster presented at the 2008 California/Hawaii Regional Meeting of the Society for General Internal Medicine. San Francisco, CA; March 1, 2008.
Download Abstract PDF or Download Poster PDF

Hankin C, Wang Z, Bronstone A. Racial disparities in the initiation of psychotropics among Medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder: large-scale, retrospective Florida Medicaid claims analysis (Submission # 2-0662). Poster presented at the 42nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists; Las Vegas, NV; December 2-4, 2007. Download Abstract PDF or Download Poster PDF

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Hankin CS, Pankratz VS, Mrazek DA, Jacobsen SJ. Gender differences in psychoactive medication treatment for attention-deficit/hyperactivity disorder (ADHD): Results from a population-based study. Poster presented at the 5th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Rotterdam, The Netherlands; November 3-5, 2002.

Hankin CS. The patient, family and societal burden of ADHD. Invited address at the Annual Meeting of the Southern California Chapter of the American Academy of Pediatrics Conference on ADHD. Los Angeles, CA; June 2002.

Hankin CS. ADHD and its impact on the family. Participant/Faculty Member of ADHD Clinical Roundtable. Newport Beach, CA; June, 2001.

Noe L, Hankin CS. Health outcomes of childhood attention-deficit/hyperactivity disorder (ADHD): Health care use and work status of caregivers. Poster presented at the 4th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Crystal City, MD; May 23-26, 2001. 

If you have questions about any of the presentations listed, or about another BioMedEcon presentation, please contact us.